🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral vs injectable GLP-1: bioavailability and efficacy comparison — anyone have experience? Page 6

Oral vs injectable GLP-1: bioavailability and efficacy comparison — anyone have experience?

stefan_berlin Tue, Nov 18, 2025 at 5:28 PM 45 replies 2,165 viewsPage 6 of 9
tom_AK
New Member
28
112
Jan 2026
Anchorage, AK
Dec 2, 2025 at 12:31 AM#26
roxy_nash said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Coming at roxy_nash’s question from a different direction. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

Last edited: Dec 2, 2025 at 4:31 AM
11 11steve_okc, dave_SLC, FDA_TrackerJim and 8 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Dec 3, 2025 at 3:55 PM#27

Adding the numbers, since they settle part of this. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

10 10JenPlateau, SallyK_inj, CryptoCarl and 7 others
Reply Quote Save Share Report
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Dec 5, 2025 at 7:20 AM#28

A narrower follow-up, since the general answer is now clear:

How would you tell the difference between that and the alternative explanation?

Last edited: Dec 5, 2025 at 11:20 AM
9 9Dr.ReproEndo, lucas_SP_BR, lisa_labSD and 6 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Dec 6, 2025 at 10:46 PM#29
HPLC_Greg said:
One habit that pays for itself: post the method alongside the number.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

Last edited: Dec 7, 2025 at 12:46 AM
8 8TomTeleRx, DoseLogDan, SleepFixSam and 5 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Dec 8, 2025 at 2:12 PM#30

Closing the loop on my own question.

Update — tachyphylaxis to the gastric effect, persistence of the appetite effect. Two curves, and I had been watching the wrong one.

36 11TrialTracker_MD, JennaRN, LabKate and 33 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register